GMED
Globus Medical Inc

1,562
Mkt Cap
$11.58B
Volume
18.00
52W High
$94.93
52W Low
$51.79
PE Ratio
28.42
GMED Fundamentals
Price
$87.95
Prev Close
$86.02
Open
$86.10
50D MA
$65.35
Beta
1.00
Avg. Volume
1.29M
EPS (Annual)
$0.747
P/B
2.69
Rev/Employee
$475,350.00
Loading...
Loading...
News
all
press releases
Should You Buy Globus Medical (GMED) After Golden Cross?
When a stock experiences a golden cross technical event, good things could be on the horizon. How should investors react?
Zacks·20h ago
News Placeholder
More News
News Placeholder
DNB Asset Management AS Boosts Stake in Globus Medical, Inc. $GMED
DNB Asset Management AS increased its holdings in shares of Globus Medical, Inc. (NYSE:GMED - Free Report) by 15.7% during the second quarter, according to its most recent disclosure with the...
MarketBeat·1d ago
News Placeholder
Globus Medical, Inc. $GMED Shares Purchased by Segall Bryant & Hamill LLC
Segall Bryant & Hamill LLC grew its holdings in shares of Globus Medical, Inc. (NYSE:GMED - Free Report) by 6.7% in the 2nd quarter, according to the company in its most recent filing with the...
MarketBeat·2d ago
News Placeholder
Globus Medical, Inc. $GMED Shares Sold by ProShare Advisors LLC
ProShare Advisors LLC lessened its stake in Globus Medical, Inc. (NYSE:GMED - Free Report) by 46.9% in the 2nd quarter, according to the company in its most recent Form 13F filing with the SEC. The...
MarketBeat·2d ago
News Placeholder
Dynamic Technology Lab Private Ltd Purchases Shares of 25,853 Globus Medical, Inc. $GMED
Dynamic Technology Lab Private Ltd purchased a new position in shares of Globus Medical, Inc. (NYSE:GMED - Free Report) during the second quarter, according to the company in its most recent Form 13F...
MarketBeat·4d ago
News Placeholder
DXCM Stock Falls Despite FDA Clearance for Dexcom Smart Basal
DexCom receives FDA clearance for DexCom Smart Basal titration software module, which optimizes basal insulin dose in type 2 diabetes patients by integrating with the G7 15 day sensor.
Zacks·5d ago
News Placeholder
Globus Medical, Inc. $GMED Stock Holdings Decreased by KBC Group NV
KBC Group NV lessened its stake in Globus Medical, Inc. (NYSE:GMED - Free Report) by 6.9% during the second quarter, according to the company in its most recent 13F filing with the SEC. The...
MarketBeat·7d ago
News Placeholder
5 Top Stocks Driven by Strong Relative Price Strength Now
PARR, AU, GMED, ALNT and SNDK emerge as top picks after posting gains, rising estimates and sustained relative price outperformance.
Zacks·8d ago
News Placeholder
Banco Bilbao Vizcaya Argentaria S.A. Purchases 7,711 Shares of Globus Medical, Inc. $GMED
Banco Bilbao Vizcaya Argentaria S.A. increased its position in shares of Globus Medical, Inc. (NYSE:GMED - Free Report) by 7.0% during the second quarter, according to the company in its most recent...
MarketBeat·8d ago
News Placeholder
Globus Medical, Inc. $GMED Shares Bought by Candriam S.C.A.
Candriam S.C.A. lifted its stake in shares of Globus Medical, Inc. (NYSE:GMED - Free Report) by 15.3% in the 2nd quarter, according to the company in its most recent 13F filing with the Securities...
MarketBeat·9d ago

Latest GMED News

View

Advertisement|Remove ads.

Advertisement|Remove ads.